CLBT on Nasdaq
Cellebrite DI Ltd.
Prepackaged software services company, listed on Nasdaq (CLBT). Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Xunlei Limited, PagerDuty or Sprout Social, Inc., or pick any stock.
- TickerCLBT on Nasdaq1
- IndustryServices-Prepackaged Software1
- Business address94 Shlomo Shmelzer Road, Petah Tikva, L3 49706022
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
We were incorporated on April 13, 1999 as a private limited liability company under the laws of the State of Israel. We are registered under the Israeli Companies Law as Cellebrite DI Ltd., and our registration number with the Israeli Registrar of Companies is 51-276657-7.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
84.2%Gross margin4
14.0%Operating margin4
16.5%Net margin4
18.6%Revenue growth, 20254
16.2%Return on equity4
$160.3MFree cash flow4
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Subscription Services brought in 70% of the revenue Cellebrite DI Ltd. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Subscription Services | $209.8M | $271.0M | $330.8M |
| Term-Licenses | $70.7M | $82.0M | $96.2M |
| Professional Services | $31.1M | $30.9M | $30.9M |
| Other non-recurring | $13.6M | $17.3M | $17.8M |
Regions
Americas brought in 54% of the revenue Cellebrite DI Ltd. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Americas | $172.2M | $215.5M | $256.6M |
| EMEA | $112.2M | $134.9M | $161.4M |
| Asia Pacific | $40.7M | $50.8M | $57.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue16¢$75.2M
- Research and development24¢$113.9M
- Other costs41¢$195.9M
- Income tax3¢$12.4M
- Profit16¢$78.3M
Out of $475.7M in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending8¢$13.2M
- Kept or used elsewhere92¢$160.3M
Out of $173.5M of cash from operations.4
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $475.7M | $401.2M | $325.1M |
| Cost of Revenue | $75.2M | $62.6M | $53.2M |
| Gross Profit, Total | $400.5M | $338.6M | $271.9M |
| Research and Development Expense | $113.9M | $98.4M | $84.4M |
| Selling and Marketing Expense | $154.8M | $132.4M | $110.8M |
| General and Administrative Expense | $65.3M | $50.9M | $43.4M |
| Operating Expenses, Total | $334.0M | $281.7M | $238.6M |
| Operating Income (Loss), Total | $66.5M | $56.9M | $33.2M |
| Nonoperating Income (Expense) | $24.2M | -$332.9M | -$108.8M |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total | $90.7M | -$276.0M | -$75.6M |
| Income Tax Expense (Benefit) | $12.4M | $7.0M | $5.5M |
| Net Income (Loss) | $78.3M | -$283.0M | -$81.1M |
| Basic net income (loss) per share attributable to ordinary shareholders | $77.8M | -$283.0M | -$81.1M |
| Basic net income (loss) per ordinary share (in USD per share) | $0.32 | -$1.35 | -$0.43 |
| Diluted net income (loss) per share (in USD per share) | $0.31 | -$1.35 | -$0.43 |
| Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares) | 241.6M shares | 209.5M shares | 190.2M shares |
| Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares) | 249.9M shares | 209.5M shares | 190.2M shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $124.5M | $191.7M | ||
| Short-term deposits | $161.0M | $153.7M | ||
| Marketable securities | $151.5M | $101.8M | ||
| Trade receivables (net of allowance for credit losses of $506 and $594 as of December 31, 2025 and December 31, 2024, respectively) | $105.0M | $82.4M | ||
| Prepaid expenses and other current assets | $19.6M | $23.2M | ||
| Contract acquisition costs | $6.6M | $5.8M | ||
| Inventories | $7.6M | $8.9M | ||
| Total current assets | $575.9M | $567.6M | ||
| Other non-current assets | $14.6M | $7.7M | ||
| Marketable securities | $98.0M | $36.6M | ||
| Deferred tax assets, net | $10.9M | $11.1M | ||
| Property and equipment, net | $22.2M | $17.0M | ||
| Operating Lease, Right-of-Use Asset | $16.3M | $10.6M | ||
| Intangible assets, net | $81.5M | $11.3M | ||
| Goodwill | $119.6M | $28.7M | ||
| Total non-current assets | $363.0M | $123.0M | ||
| Total assets | $938.9M | $690.6M | ||
| Trade payables | $16.8M | $11.1M | ||
| Deferred revenues | $277.6M | $217.0M | ||
| Other accounts payable and accrued expenses | $71.2M | $63.3M | ||
| Operating lease liabilities | $4.0M | $4.1M | ||
| Total current liabilities | $369.7M | $295.5M | ||
| Other long-term liabilities | $16.7M | $7.0M | ||
| Operating lease liabilities | $18.7M | $6.8M | ||
| Deferred revenues | $49.5M | $45.2M | ||
| Total long-term liabilities | $84.9M | $59.0M | ||
| Total liabilities | $454.5M | $354.5M | ||
| Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized, 248,622,818 and 234,566,473 shares issued and 248,581,042 and 234,524,697 shares outstanding as of December 31, 2025 and 2024, respectively | $0 | $0 | ||
| Additional paid-in capital | $568.7M | $498.9M | ||
| Common stock par value per share (in NIS per share) | 0.00 ILS | 0.00 ILS | ||
| Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares | -$85.0K | -$85.0K | ||
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $2.2M | $2.1M | ||
| Accumulated deficit | -$86.5M | -$164.9M | ||
| Total Shareholders equity | $484.3M | $336.0M | $34.2M | $73.9M |
| Total liabilities and shareholders equity | $938.9M | $690.6M | ||
| Trade receivable, allowance for credit loss | $506.0K | $594.0K | ||
| Common stock, shares authorized (in shares) | 3.5B shares | 3.5B shares | ||
| Common Stock, Shares, Issued | 248.6M shares | 234.6M shares | ||
| Common stock shares outstanding (in shares) | 248.6M shares | 234.5M shares | ||
| Treasury Stock, Common, Shares | 41.8K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $124.5M | $191.7M | ||
| Short-term deposits | $161.0M | $153.7M | ||
| Marketable securities | $151.5M | $101.8M | ||
| Trade receivables (net of allowance for credit losses of $506 and $594 as of December 31, 2025 and December 31, 2024, respectively) | $105.0M | $82.4M | ||
| Prepaid expenses and other current assets | $19.6M | $23.2M | ||
| Contract acquisition costs | $6.6M | $5.8M | ||
| Inventories | $7.6M | $8.9M | ||
| Total current assets | $575.9M | $567.6M | ||
| Other non-current assets | $14.6M | $7.7M | ||
| Marketable securities | $98.0M | $36.6M | ||
| Deferred tax assets, net | $10.9M | $11.1M | ||
| Property and equipment, net | $22.2M | $17.0M | ||
| Operating Lease, Right-of-Use Asset | $16.3M | $10.6M | ||
| Intangible assets, net | $81.5M | $11.3M | ||
| Goodwill | $119.6M | $28.7M | ||
| Total non-current assets | $363.0M | $123.0M | ||
| Total assets | $938.9M | $690.6M | ||
| Trade payables | $16.8M | $11.1M | ||
| Deferred revenues | $277.6M | $217.0M | ||
| Other accounts payable and accrued expenses | $71.2M | $63.3M | ||
| Operating lease liabilities | $4.0M | $4.1M | ||
| Total current liabilities | $369.7M | $295.5M | ||
| Other long-term liabilities | $16.7M | $7.0M | ||
| Operating lease liabilities | $18.7M | $6.8M | ||
| Deferred revenues | $49.5M | $45.2M | ||
| Total long-term liabilities | $84.9M | $59.0M | ||
| Total liabilities | $454.5M | $354.5M | ||
| Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized, 248,622,818 and 234,566,473 shares issued and 248,581,042 and 234,524,697 shares outstanding as of December 31, 2025 and 2024, respectively | $0 | $0 | ||
| Additional paid-in capital | $568.7M | $498.9M | ||
| Common stock par value per share (in NIS per share) | 0.00 ILS | 0.00 ILS | ||
| Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares | -$85.0K | -$85.0K | ||
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $2.2M | $2.1M | ||
| Accumulated deficit | -$86.5M | -$164.9M | ||
| Total Shareholders equity | $484.3M | $336.0M | $34.2M | $73.9M |
| Total liabilities and shareholders equity | $938.9M | $690.6M | ||
| Trade receivable, allowance for credit loss | $506.0K | $594.0K | ||
| Common stock, shares authorized (in shares) | 3.5B shares | 3.5B shares | ||
| Common Stock, Shares, Issued | 248.6M shares | 234.6M shares | ||
| Common stock shares outstanding (in shares) | 248.6M shares | 234.5M shares | ||
| Treasury Stock, Common, Shares | 41.8K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net Income (Loss) | $78.3M | -$283.0M | -$81.1M |
| Share-based compensation | $44.9M | $30.6M | $19.0M |
| Amortization of premium, discount and accrued interest on marketable securities | -$2.4M | -$2.9M | -$1.1M |
| Depreciation and amortization | $11.9M | $10.6M | $10.0M |
| Disposal and write-off of property and equipment | $554.0K | $0 | $0 |
| Abandonment of right-of-use assets and disposal of leasehold improvements | $1.8M | $0 | $0 |
| Interest on deposits and investments | -$8.2M | -$10.7M | -$7.7M |
| Deferred tax assets, net | $75.0K | -$4.0M | $5.1M |
| Remeasurement of Warrant liability | $0 | $110.7M | $34.1M |
| Remeasurement of Restricted Sponsor Shares liability | $0 | $65.9M | $29.7M |
| Remeasurement of Price Adjustment Shares liability | $0 | $173.1M | $55.5M |
| (Increase) decrease in trade receivables | -$15.8M | -$5.8M | $2.3M |
| Increase in deferred revenues | $49.8M | $22.3M | $46.1M |
| Increase in other non-current assets | -$6.9M | -$341.0K | -$5.6M |
| Decrease (increase) in prepaid expenses and other current assets | $5.6M | $3.2M | -$9.2M |
| Changes in operating lease right-of-use assets | $4.6M | $5.3M | $4.4M |
| Changes in operating lease liabilities | $547.0K | -$4.8M | -$4.2M |
| Decrease in inventories | $1.6M | $982.0K | $243.0K |
| Increase in trade payables | $4.9M | $2.8M | $3.7M |
| Increase in other accounts payable and accrued expenses | $4.2M | $17.6M | $734.0K |
| (Decrease) increase in other long-term liabilities | -$2.0M | $880.0K | $121.0K |
| Net Cash Provided by (Used in) Operating Activities, Total | $173.5M | $132.2M | $102.1M |
| Payments to Acquire Property, Plant, and Equipment | -$13.2M | -$8.6M | -$5.2M |
| Payments to Acquire Businesses, Net of Cash Acquired | -$147.5M | -$2.7M | $0 |
| Payments to Acquire Intangible Assets | $0 | -$2.0M | -$2.7M |
| Payments to Acquire Marketable Securities | -$321.2M | -$127.8M | -$55.3M |
| Proceeds from maturity of marketable securities | $153.0M | $60.0M | $56.3M |
| Proceeds from sales of marketable securities | $59.8M | $0 | $0 |
| Payments to Acquire Short-Term Investments | -$187.0M | -$207.0M | -$89.0M |
| Proceeds from Sale of Short-Term Investments | $187.9M | $138.7M | $73.4M |
| Net Cash Provided by (Used in) Investing Activities, Total | -$268.2M | -$149.5M | -$22.5M |
| Exercise of options | $20.1M | $17.3M | $19.1M |
| Proceeds from Employee Share Purchase Plan | $5.0M | $3.3M | $2.6M |
| Exercise of public warrants | $0 | $53.0K | $0 |
| Redemption of public warrants | $0 | -$11.0K | $0 |
| Net cash provided by financing activities | $25.1M | $20.7M | $21.8M |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect, Total | -$69.7M | $3.3M | $101.3M |
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | $2.5M | -$1.2M | $589.0K |
| Income Taxes Paid, Net | -$549.0K | $7.7M | $10.0M |
| Operating lease liabilities arising from obtaining right of use assets | $11.2M | $1.9M | $4.4M |
| Reclass and release of Restricted Sponsor Share | $0 | $113.1M | $0 |
| Reclassification and issuance of Price Adjustment Share | $0 | $254.8M | $0 |
| Reclassification and issuance of Price Adjustment Share | $0 | $164.8M | $0 |
| Unrealized gain (loss) on marketable securities, tax | $35.0K | $33.0K | $2.0K |
| Unrealized gain (loss) on hedging transactions, tax | $152.0K | $66.0K | $171.0K |
| Change in foreign currency translation adjustment | -$1.3M | $1.4M | -$1.0M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Cellebrite DI Ltd., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerShiven Ramji Sep 25, 2026 to now9
- PresidentShiven Ramji May 7, 2026 to now10
- Chief financial officerDavid Barter Jul 9, 2026 to now11
Board members and other officers (16)
- Chief Technology OfficerChristopher Michael Wade Mar 18, 2026 to now12
- OfficerDavid Barter Mar 18, 2026 to now13
- OfficerHolly B. Windham Mar 18, 2026 to now14
- Global Chief Revenue OfficerMarcus Jewell Mar 18, 2026 to now15
- OfficerRonnen Armon Mar 18, 2026 to now16
- Chief Information OfficerSigalit Shavit Mar 18, 2026 to now17
- Chief People OfficerZohar Tadmor-Eilat Mar 18, 2026 to now18
- Board memberAdam Clammer Mar 18, 2026 to now19
- Board memberBuren Brandon Van Mar 18, 2026 to now20
- Board memberDafna Gruber Mar 18, 2026 to now21
- Board memberMichael David Capellas Mar 18, 2026 to now22
- Board memberNadine Baudot-Trajtenberg Mar 18, 2026 to now23
- Board memberRyusuke Utsumi Mar 18, 2026 to now24
- Board memberTroy Richardson Mar 18, 2026 to now25
- Board memberYonatan Domnitz Mar 18, 2026 to now26
- Board memberShiven Ramji Sep 25, 2026 to now9
Timeline
- Sep 25, 2026New chief executive Shiven Ramji becomes CEO9
Filings
319 filings to the SEC since October 2021: 7 annual reports, 40 insider forms, 17 large holders, 255 other. The latest 20:
- Oct 9, 2026SCHEDULE 13G EDGAR
- Oct 7, 2026144 EDGAR
- Sep 29, 20264 PRIMARY DOCUMENT EDGAR
- Sep 29, 20264 PRIMARY DOCUMENT EDGAR
- Sep 28, 20264 EDGAR
- Sep 25, 20264 EDGAR
- Sep 24, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 17, 20264 EDGAR
- Sep 17, 20264 EDGAR
- Sep 17, 20264 EDGAR
- Sep 17, 20264 EDGAR
- Sep 2, 20266-K CURRENT REPORT EDGAR
- Aug 27, 20264 EDGAR
- Aug 25, 20264 EDGAR
- Aug 24, 2026144 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 2026144 EDGAR
- Aug 19, 2026144 EDGAR
- Aug 19, 2026144 EDGAR
The 319 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
13 open-market trades by officers, directors and large owners since October 2021: 0 buys and 13 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Hogan Thomas E. | Sale | 25,299 | $11.29 | $285.6K | Form 4 |
| Aug 24, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 4,323 | $11.36 | $49.1K | Form 4 |
| Aug 21, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 12,562 | $11.24 | $141.2K | Form 4 |
| Aug 21, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 2,198 | $11.24 | $24.7K | Form 4 |
| Aug 12, 2026 | Hogan Thomas E. | Sale | 139,713 | $15.39 | $2.2M | Form 4 |
| Aug 12, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 411 | $16.07 | $6.6K | Form 4 |
| Aug 12, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 230 | $16.07 | $3.7K | Form 4 |
| Jul 8, 2026 | Barter DavidChief Financial Officer | Sale | 41,734 | $16.38 | $683.6K | Form 4 |
| Jul 2, 2026 | Hogan Thomas E. | Sale | 103,188 | $15.76 | $1.6M | Form 4 |
| May 21, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 5,673 | $13.13 | $74.5K | Form 4 |
| May 18, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 12,658 | $12.77 | $161.6K | Form 4 |
| May 12, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 228 | $13.01 | $3.0K | Form 4 |
| May 12, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 383 | $13.01 | $5.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Pertento Partners LLPSCHEDULE 13G, 1 filing Oct 9, 202627
- Voss Capital, LPSCHEDULE 13G, 1 filing Aug 18, 202628
- SuncorporationSCHEDULE 13G/A, 5 filings Feb 10, 2022 to Feb 24, 202629
- FMR LLCSCHEDULE 13G/A, 2 filings Feb 12, 2025 to May 12, 202530
- TWC Tech Holdings II, LLCSCHEDULE 13D/A, 3 filings Aug 29, 2024 to Mar 20, 202531
- IGP SAFERWORLD, LIMITED PARTNERSHIPSCHEDULE 13G/A, 4 filings Feb 24, 2022 to Feb 11, 202532
- Weiss Asset Management LPSC 13G/A, 1 filing Feb 7, 202233
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARShiven Ramji, President
- 11
- 12
- 13SEC EDGARDavid Barter, Officer
- 14SEC EDGARHolly B. Windham, Officer
- 15
- 16SEC EDGARRonnen Armon, Officer
- 17
- 18
- 19SEC EDGARAdam Clammer, Board member
- 20SEC EDGARBuren Brandon Van, Board member
- 21SEC EDGARDafna Gruber, Board member
- 22SEC EDGARMichael David Capellas, Board member
- 23
- 24SEC EDGARRyusuke Utsumi, Board member
- 25SEC EDGARTroy Richardson, Board member
- 26SEC EDGARYonatan Domnitz, Board member
- 27
- 28
- 29
- 30
- 31
- 32
- 33